» Articles » PMID: 29221636

Urothelial Neoplasms in Pediatric and Young Adult Patients: A Large Single-center Series

Overview
Journal J Pediatr Surg
Date 2017 Dec 10
PMID 29221636
Citations 10
Authors
Affiliations
Soon will be listed here.
Abstract

Purpose: Bladder cancer is the sixth most common cancer in the United States, but is exceedingly rare in young patients, leading to a lack of accepted standards for diagnosis, treatment, and surveillance. We review our institutional experience with bladder urothelial neoplasms in pediatric and young adult patients summarizing presentation, treatment, and outcomes.

Methods: Surgical pathology records at our institution were searched for cases of urothelial neoplasms among patients ≤25 years of age treated between January 1997 and September 2016. Cases submitted exclusively for pathology review were excluded. Diagnoses were confirmed based on pathologic examination using the 2004 World Health Organization classification system.

Results: Thirty-four patients were identified with a mean age of 21.1 years (range 8-25 years), and median follow-up was 25.1 months (1-187 months). The male to female ratio was 1.83:1. The most common presenting symptom was hematuria (n=26; 76%). Diagnoses were invasive urothelial carcinoma (n=3), noninvasive urothelial carcinoma (n=24), PUNLMP (n=6), and urothelial papilloma (n=1). Noninvasive lesions were resected by cystoscopy, after which 12% (n=4) experienced complications (grade II or greater). One patient with stage IV invasive disease at diagnosis died, and 2 patients developed recurrences. Of those with noninvasive carcinoma, 29% (n=7) required repeat cystoscopy soon after initial TURBT at outside institutions, and 17% (n=4) had tumors downgraded from high-grade to low-grade after pathology review.

Conclusion: Hematuria is the most common sign of bladder neoplasia in children and young adults and should be investigated by cystoscopy. The majority of urothelial neoplasms in these patients are noninvasive and can be successfully treated with transurethral resection.

Level Of Evidence: Level IV (Retrospective study with no comparison group).

Citing Articles

[Urinary bladder: tumor precursors and non-invasive carcinoma].

Lange F, Hartmann A, Eckstein M Pathologie (Heidelb). 2024; 46(1):21-26.

PMID: 39532726 DOI: 10.1007/s00292-024-01385-8.


Bladder Neoplasia in Pediatric Patients-A Single-Center Experience Including a Case Series.

Haecker F, Bruder E Children (Basel). 2023; 10(10).

PMID: 37892259 PMC: 10605940. DOI: 10.3390/children10101596.


Pediatric genitourinary tumors: Distribution, demographics, and outcomes.

Nazemi A, Daneshmand S, Chang A Pediatr Investig. 2022; 6(2):85-92.

PMID: 35774527 PMC: 9218969. DOI: 10.1002/ped4.12318.


Immunotherapy With Bacillus Calmette-Guerin (BCG) in a 16-Year-Old With Urothelial Bladder Carcinoma.

Martinez-Thomas J, Galicia-Belaunzaran L, Merayo-Chalico C, Palatchi J, Angulo-Lozano J Cureus. 2022; 14(5):e24994.

PMID: 35719797 PMC: 9191261. DOI: 10.7759/cureus.24994.


Coexistent urothelial papilloma and ureteric calculus in an 8-year-old child: A rare co-occurrence.

Agnihotri M, Sathe P J Postgrad Med. 2020; 67(3):182-183.

PMID: 33380592 PMC: 8445120. DOI: 10.4103/jpgm.JPGM_300_20.


References
1.
Fine S, Humphrey P, Dehner L, Amin M, Epstein J . Urothelial neoplasms in patients 20 years or younger: a clinicopathological analysis using the world health organization 2004 bladder consensus classification. J Urol. 2005; 174(5):1976-80. DOI: 10.1097/01.ju.0000176801.16827.82. View

2.
Di Carlo D, Ferrari A, Perruccio K, DAngelo P, Fagnani A, Cecchetto G . Management and follow-up of urothelial neoplasms of the bladder in children: a report from the TREP project. Pediatr Blood Cancer. 2014; 62(6):1000-3. DOI: 10.1002/pbc.25380. View

3.
Berrettini A, Castagnetti M, Salerno A, Nappo S, Manzoni G, Rigamonti W . Bladder urothelial neoplasms in pediatric age: experience at three tertiary centers. J Pediatr Urol. 2014; 11(1):26.e1-5. DOI: 10.1016/j.jpurol.2014.08.008. View

4.
Comperat E, Larre S, Roupret M, Neuzillet Y, Pignot G, Quintens H . Clinicopathological characteristics of urothelial bladder cancer in patients less than 40 years old. Virchows Arch. 2015; 466(5):589-94. DOI: 10.1007/s00428-015-1739-2. View

5.
Wild P, Giedl J, Stoehr R, Junker K, Boehm S, van Oers J . Genomic aberrations are rare in urothelial neoplasms of patients 19 years or younger. J Pathol. 2006; 211(1):18-25. DOI: 10.1002/path.2075. View